SI-BONE Inc (SIBN) Exchange: NASDAQ

SI-BONE, Inc. is a medical device company based in San Jose, California that markets and sells products to treat patients with back pain due to sacroiliac joint (SIJ) dysfunction. Founded in 2007, the company has grown into an industry leader in SIJ treatment, pioneering and commercializing two groundbreaking SIJ fusion implants and other medical devices and recurring consumable supplies. SI-BONE is committed to advancing the science and research behind the diagnosis and treatment of SIJ disorders through its partnerships with researchers, orthopaedic trauma surgeons, and leading healthcare institutions around the world. The company’s management team and board of directors combine substantial leadership and experience in the medical device industry and have led the company from a start-up to a successful public company, trading as SIBN on the Nasdaq Global Market. SI-BONE is also dedicated to patient access and affordability, offering a number of cost-saving programs, such as product bundling and a generous patient assistance program. The company’s commitment to quality and patient care is unwavering and led to the achievement of ISO 13485 certification. The mission of SI-BONE, Inc. is to provide improved clinical outcomes for patients suffering from SIJ dysfunction and reduce their pain and suffering.